Studying alloknesia in atopic dermatitis
Part of Immune system & allergy, Skin clinical trials.
This study looks at a condition called alloknesia (a feeling that a light touch is painful) in people with atopic dermatitis (a type of eczema). It aims to understand how common this is and what it feels like.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with atopic dermatitis (eczema) for more than 6 months.
- You must be able to fill out questionnaires (physically and mentally).
- You must not have been on systemic (whole-body) treatment for eczema for 1 month or more before the study.
- You must not be under legal guardianship or court protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people view those with certain skin conditions. It aims to understand stigma, which may help improve awareness and support.
This study looks at how people with atopic dermatitis (eczema) take part in clinical trials. It aims to understand what helps or hinders participation, so future trials can be more patient-friendly.
This study looks at how often the eyelids are affected in adults with atopic dermatitis (a long-term skin condition). It may help doctors better understand patterns of skin and eyelid symptoms so care can be improved.
This study gathers information from people around the world who have atopic dermatitis (eczema). It aims to better understand the condition and how it affects people's lives.
This observational study follows people with eczema (atopic dermatitis) and sometimes related allergies over time, even if they keep their usual medical treatments. It may help researchers better understand how these conditions change and what factors relate to symptoms.
This study looks at the skin’s germs (“microbiome”) in people with atopic dermatitis (eczema) or psoriasis. It may help researchers better understand what’s going on on the skin and how that might relate to disease severity.
Hear when a new Atopic Dermatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.